Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6121460 | Journal of Clinical Virology | 2012 | 4 Pages |
Abstract
These data suggest that the increase in morbidity and mortality observed in recent HAdV-14p1 infections is not due to viral growth or cellular infectivity differences from the prototypic HAdV-14 strain. While there were some statistically important differences detected between strains in cytotoxicity and plaque morphology assays, it seems more likely that other factors, such as environmental stressors, co-infections, or individual host response are likely contributing to the increase in morbidity.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Benjamin D. Anderson, Kelli L. Barr, Gary L. Heil, John A. Friary, Gregory C. Gray,